Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/43467
Title: Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
Authors: Levin, Raquel [UNIFESP]
Almeida, Valeria [UNIFESP]
Peres, Fernanda Fiel [UNIFESP]
Calzavara, Mariana Bendlin [UNIFESP]
Silva, Neide Derci da [UNIFESP]
Suiama, Mayra Akimi [UNIFESP]
Niigaki, Suzy Tamie [UNIFESP]
Zuardi, Antonio Waldo [UNIFESP]
Hallak, Jaime Eduardo Cecilio
Crippa, Jose Alexandre de Souza
Abilio, Vanessa Costhek [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
CNPq
Keywords: Schizophrenia
cannabidiol
rimonabant
contextual fear conditioning
SHR
Issue Date: 1-Nov-2012
Publisher: Bentham Science Publ Ltd
Citation: Current Pharmaceutical Design. Sharjah: Bentham Science Publ Ltd, v. 18, n. 32, p. 4960-4965, 2012.
Abstract: Objectives: Clinical and neurobiological findings suggest that cannabinoids and their receptors are implicated in schizophrenia. Cannabidiol (CBD), a non-psychotomimetic compound of the Cannabis sativa plant, has been reported to have central therapeutic actions, such as antipsychotic and anxiolytic effects. We have recently reported that spontaneously hypertensive rats (SHR) present a deficit in contextual fear conditioning (CFC) that is specifically ameliorated by antipsychotics and aggravated by proschizophrenia manipulations. These results led us to suggest that the CFC deficit presented by SHR could be used as a model to study emotional processing impairment in schizophrenia. The aim of this study is to evaluate the effects of CBD and rimonabant (CB1 receptor antagonist) on the contextual fear conditioning in SHR and Wistar rats (WR). Methods: Rats were submitted to CFC task after treatment with different doses of CBD (experiment 1) and rimonabant (experiment 2). Results: In experiment 1, SHR showed a decreased freezing response when compared to WR that was attenuated by 1 mg/kg CBD. Moreover, all CBD-treated WR presented a decreased freezing response when compared to control rats. In experiment 2, SHR showed a decreased freezing response when compared to WR that was attenuated by 3 mg/kg rimonabant. Discussion: Our results suggest a potential therapeutical effect of CBD and rimonabant to treat the emotional processing impairment presented in schizophrenia. In addition, our results reinforce the anxiolytic profile of CBD.
URI: http://repositorio.unifesp.br/11600/43467
ISSN: 1381-6128
Other Identifiers: http://dx.doi.org/10.2174/138161212802884735
Appears in Collections:Resenha
Resenha

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.